Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell and its environment ...

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.

Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of ...

Can your liver heal itself? An expert explains liver regeneration, recovery timeline, and warning signs to watch out for this ...

Izalontamab brengitecan (iza-bren) is an antibody-drug conjugate and bispecific antibody undergoing evaluation in small cell ...

Glioma remains one of the deadliest brain cancers, characterized by aggressive growth and limited treatment options. In a new study, researchers from Ningxia Medical University uncovered that choline ...

Black Diamond Therapeutics, Inc. BDTX is building its equity story around a single, high-leverage asset: silevertinib, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) ...

Leah Phillips, a Kentucky mom of three, said she was initially told her symptoms were due to a cold, allergies or anxiety ...

The Phase II cohort analysis included 145 patients whose conditions had progressed following initial chemotherapy.

PICALM, a protein boosted by exercise and fasting, plays a critical role in muscle cell development. It controls cellular ...